Australia

Alterity Therapeutics Announces Presentation of Data from the bioMUSE Natural History Study at the American Autonomic Society Annual Meeting

MELBOURNE, Australia and SAN FRANCISCO, Nov. 7, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced a poster presentation fro...

2022-11-07 23:25 3412

Certa Therapeutics' investigational drug FT011 delivers breakthrough results as a potential novel treatment for serious inflammatory and fibrotic diseases

* Research presented today by University of Michigan Medical School highlights FT011's ground-breaking treatment potential from human expression profiles in chronic kidney disease study supported by animal model data * The research demonstrated that treatment with FT011 results in a remarkable...

2022-11-04 20:00 3180

Microsoft overtakes Amazon in Interbrand's 2022 Best Global Brands Report

- Apple retains top spot as the Top 100 Brands ranking exceeds more than $3 trillion for the first time - a 16% increase since 2021 - Airbnb (#54), Red Bull (#64) and Xiaomi (#84) are new entrants for 2022 - Microsoft (#2), Tesla (#12) and Chanel (#22) see the greatest YoY growth - Nike (#10) en...

2022-11-04 02:24 3479

LiveHire Announced as a Member on Newly Launched AMS Verified

MIAMI, Nov. 3, 2022 /PRNewswire/ -- LiveHire, the globally-leading direct sourcing and total talent platform, announced its membership on the newly launched AMS Verified platform. LiveHire and AMS launched a strategic alliance in 2021 to expand their joint offering to enterprises inNorth America....

2022-11-03 23:03 3273

The future you desire. The life of your dreams. See it, feel it, believe it. Get ready to receive it with LIFEBOARD VR.

SYDNEY, Oct. 26, 2022 /PRNewswire/ -- The first of its kind and totally unique – Lifeboard VR is a ground-breaking new manifestation platform to help users bring to reality their dreams and goals. It's time to enter a fully immersive virtual reality world where you can customize your vision boar...

2022-10-26 21:01 2811

Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting

MELBOURNE, Australia and SAN FRANCISCO , Oct. 26, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced a poster presentation f...

2022-10-26 19:25 3232

Acting coach of EUPHORIA star Jacob Elordi and other stars launches new book, spills secrets on how to land the role of a lifetime; and working with De Niro, Pacino and Spielberg

SYDNEY, Oct. 25, 2022 /PRNewswire/ -- World-renowned Australian acting coach Les Chantery has written his first book,Life in a Mid-Shot, a bold new approach to screen auditions proven to land actors the part of their dreams. A conversation on set with Al Pacino in 2007 prompted an ah-ha moment fo...

2022-10-26 00:00 2833

BGI Australia Receives NATA Certification for Clinical Whole Exome Sequencing

BRISBANE, Australia, Oct. 20, 2022 /PRNewswire/ -- BGI Australia's lab has achieved accreditation from the National Association of Testing Authorities (NATA) to perform clinical Whole Exome Sequencing inAustralia, paving the way for the global life sciences company to provide clinical sequencing ...

2022-10-20 15:27 2194

Symbio extends its Asia expansion into Taiwan

SYDNEY, Oct. 19, 2022 /PRNewswire/ -- Symbio Holdings Limited (ASX: SYM), a leading voice communications software provider, today marked the next milestone in itsAsia-Pacific expansion strategy, announcing it will open service availability inTaiwan in 2023. With the Taiwanese Data Centre marke...

2022-10-19 15:35 2385

PIVALATE ACHIEVES POSITIVE PHASE 2 DATA IN BRAIN METS TRIAL

* F-18 Pivalate PET shows high uptake regardless of origin of primary tumour * F-18 Pivalate can be used to monitor cerebral metastases * Patients without previous external beam radiation show higher tumour uptake, while those previously treated show a trend towards lower uptake MELBOURNE, A...

2022-10-19 11:12 1901

Australian parcel theft rockets to an all-time high with the second largest rise than any other country globally

* First global report on parcel theft * Over a third of Australians affected by parcel theft or loss in lifetime * One in ten people globally are now reluctant to shop online because of fear of theft * Australia second highest on global list of increasing parcel problems * Sharpest rise a...

2022-10-17 05:00 2161

Top 100 Tech Retail Start-Up, HIVERY, named Exporter of the Year 2022

SYDNEY, Oct. 14, 2022 /PRNewswire/ -- HIVERY, a leader in innovative AI-driven retail assortment strategy simulation & optimization solutions, was announced as a winner of the2022 Premier's NSW Exporter of the Year in recognition of its in...

2022-10-14 14:54 2026

Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Australia for the Treatment of Individuals with Multiple System Atrophy

Australia now open for study of rare, rapidly progressive Parkinsonian Disorder MELBOURNE, Australia and SAN FRANCISCO, Oct. 13, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying t...

2022-10-13 22:25 2339

Actinogen Medical Limited (ACW) announces large Xanamem® therapeutic effect in early-stage Alzheimer's Disease (AD) patients

Clinical Dementia Rating Scale - Sum of Boxes effect of 0.6 to 0.8 points observed in patients with elevated pTau biomarker with once daily, 10 mg, oral therapy SYDNEY, Oct. 10, 2022 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) today announces positive Phase 2a clinical data from its Alz...

2022-10-10 20:00 2472

First patient treated in Clarity's therapeutic prostate cancer trial

Highlights * Clarity Pharmaceuticals recruits and treats its first patient in the therapeutic phase of its SAR-bisPSMA theranostic clinical trial SECuRE (NCT04868604)[1] investigating Targeted Copper Theranostics (TCTs) in patients with metastatic castrate-resistant prostate cancer (mCRPC) ...

2022-10-07 21:06 2562

Global Milk Industry Digestibility Breakthrough

--World-first Haelen technology achieves 100% fresh, natural milk that is twice as digestible BRISBANE, Australia, Oct. 4, 2022 /PRNewswire/ -- Naturo, the company behind the world-first patented 'Haelen' milk processing technology which gives fresh milk a 60-day shelf life has achieved another ...

2022-10-05 04:00 1374

DetectedX to Provide Free Access to Radiology Online Learning Platform to Radiology Across Borders to Enhance Global Charity's Teaching Initiatives

Radiology Across Borders will Promote Access to DetectedX's On-Demand, Web-Based Educational Platform to Clinicians from Developing Nations to Improve Diagnostic Accuracy SYDNEY, Oct. 3, 2022 /PRNewswire/ -- DetectedX announced today that it will provide free access to its Radiology Online Learn...

2022-10-03 20:00 2349

Envato reveals significant growth in demand for its unlimited subscription service, as Envato Elements grows to become a market leader

MELBOURNE, Australia, Sept. 29, 2022 /PRNewswire/ -- Envato has revealed a 23% jump in subscribers on itsElements product, with an associated revenue increase of 33% year on year, off the back of another successful 12 months as one of the world's leading providers o...

2022-09-29 19:54 2409

JXSN#4 FLOWS HELIUM (6.5% He) TO SURFACE GALACTICA/PEGASUS

Highlights * JXSN#4 exploration well completed in Blue Star's Galactica/Pegasus prospect. * Analysis of gas obtained during drilling shows a calculated air-free gas composition of 6.5% helium in theLyons formation. * Both the upper and lower Lyons sands are gas charged with helium. * JXSN#4...

2022-09-29 12:48 2099

CONTINGENT RESOURCE CERTIFIED FOR VOYAGER FIELD

Highlights * 2C net unrisked contingent helium resource of 643 MMscf for Voyager (100% BNL). * High side (3C) net unrisked estimate of 1,228 MMscf. * First declaration of contingent resource at Voyager is in addition to existing prospective resources at Galactica/Pegasus, Enterprise, Argo, ...

2022-09-27 16:43 3330
1 ... 21222324252627 ... 41